Milliman Medicare Part D Rx Pricing Report

On November 4, 2016, Milliman, Inc. released a report examining the Medicare Part D program and how list prices and rebates for medications impact costs borne by patients, plans, pharmaceutical manufacturers, and the federal government.

View the full report here.

View The AIDS Institute's Press Release here.

View the slideshow presentation, "Financial Incentives in Medicare Part D"  here.